3.4(top 5%)
Impact Factor
3.7(top 5%)
extended IF
67(top 6%)
H-Index
1K
authors
1.6K
papers
27.1K
citations
3.5K
citing journals
22.3K
citing authors

Most Cited Articles of World Journal of Hepatology

TitleYearCitations
Non-alcoholic fatty liver disease: An expanded review2017369
Hepatitis B: Epidemiology and prevention in developing countries2012223
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept2010209
Non-alcoholic fatty liver disease: The diagnosis and management2015195
Hepatoprotective effect of silymarin2014194
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma2015186
Terpenoids as potential chemopreventive and therapeutic agents in liver cancer2011185
Gender and racial differences in nonalcoholic fatty liver disease2014183
Hepatitis A: Epidemiology and prevention in developing countries2012172
Role of inflammatory response in liver diseases: Therapeutic strategies2018153
Guide for diagnosis and treatment of hepatocellular carcinoma2015144
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations2013144
Hepatocellular carcinoma: A comprehensive review2015136
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma2013131
Non-alcoholic fatty liver disease in 20152015124
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges2015119
Review on immunosuppression in liver transplantation2015118
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis2015116
Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease2013111
Alcoholic liver disease2012110
Lipotoxicity in the liver2013110
Hepatocellular carcinoma: From diagnosis to treatment2015108
Infections in liver transplant recipients2011108
Bacterial infections in cirrhosis: A critical review and practical guidance2016108
Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease2015107